To use all functions of this page, please activate cookies in your browser.
My watch list
my.chemeurope.com
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
65 Current news about the topic research collaborations
rss |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
MORPHOSYS DEVELOPS NEW SCREENING TECHNOLOGY
07-Dec-2000
MorphoSys (Neuer Markt: MOR), the Munich-based biopharmaceutical company, has announced the development of a new screening method for use in conjunction with its proprietary HuCAL© technology. The method, cysteine mediated phage display, called CysDisplay™, was presented at the 11th IBC Antibody ...
MORPHOSYS AND PROCHON ANNOUNCE MILESTONE
30-Nov-2000
MorphoSys AG (Neuer Markt: Mor) and ProChon Biotech Ltd. announced today the accomplishment of the first milestone in their collaboration which started in June 2000. MorphoSys has delivered a series of human HuCALâ antibodies which proved to block the function of the ProChon target. The target is ...
MorphoSys receives first HuCAL Patent
01-Nov-2000
Munich, Germany, October 31, 2000 MorphoSys AG (Neuer Markt: MOR) announced today that the Australian Patent Office has granted a patent covering its proprietary Human Combinatorial Antibody Library (HuCAL) technology. The patent covers the design and the methods of making the HuCAL antibody ...
MorphoSys enters Cancer Collaboration with ImmunoGen
04-Oct-2000
Cambridge, USA, Martinsried/Munich, Germany, October 2, 2000 MorphoSys AG (Neuer Markt: MOR), the German biotechnology company based in Munich/Martinsried, today announced a collaboration with ImmunoGen, Inc. (NASDAQ: IMGN), a Cambridge, Massachusetts-based biotechnology company. The two ...
Merck and Gedeon Richter join research forces to beat ischaemic stroke
28-Sep-2000
Darmstadt/Germany, and Budapest/Hungary, 28.09.2000 - Merck KGaA today announced a joint research collaboration with Gedeon Richter Ltd., the largest pharmaceuticals company in Hungary. Both companies will combine their pre-clinical pharmaceutical research forces to jointly identify novel ...
